US Stock Market Closed

Dashboard

Homology Medicines, Inc. (FIXX)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity
Analyst Opinion

B

Leverage & Liquidity

H

Fundamental Variables

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

Homology Medicines, Inc. operates as a technology platform to design and develop treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.

CEO

Arthur O. Tzianabos

Employees

187,000

Industry

Ophthalmology Biopharmaceuticals

Sector

Healthcare

Headquarters

Bedford

Exchange

NASDAQ

Summary Stats

Market Cap

86.8M

Revenue

-

Net Income

-

EPS

$0.00

Price-to-Earnings

-

Price-to-Book

-

Debt-to-Equity

-

News

Analyst Ratings

Price targets projected by 9 analysts

High

$37.00

Average

$29.00

Low

$15.00

Ratings calculated by 9 analysts

Buy

9

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Missed by -$0.12

Actual

-$0.59 -25.5%

Consensus

-0.47

Report Date

Year Ago

-0.54

Year Ago Change %

Down 9%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites